-
Product Insights
Likelihood of Approval Analysis for X Chromosome Disorders
Overview How likely is it that the drugs in X Chromosome Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. X Chromosome Disorders Overview X chromosome disorders, also termed X-linked disorders,...
-
Product Insights
Likelihood of Approval Analysis for Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Overview How likely is it that the drugs in Skin And Skin Structure Infections (SSSI) Caused By Bacteria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Skin And Skin Structure Infections...
-
Thematic Analysis
Rare Disease ​Pipeline Analysis ​Landscape, 2023
This report investigates the Rare Disease ​Pipeline Analysis ​Landscape in 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize these trends within your sector.
-
Sector Analysis
Brazil Oilseeds Market Summary, Competitive Analysis and Forecast to 2028
Brazil Oilseeds Market Report Overview The Brazilian oilseeds market size was $19.82 billion in 2023. The oilseeds market in Brazil is influenced by several macroeconomic factors, such as rising GDP, population growth, changing dietary habits, and trade agreements. In the future, the market will grow at a CAGR of more than 2% during 2023-2028. The rising demand for biofuels, notably biodiesel, stands as a significant driver within the oilseeds market. Consequently, the oilseeds market is witnessing a transformative shift towards...
-
Sector Analysis
NewSouth Asia Construction Market Size, Share, Trends, and Analysis by Sector, Country and Segment Forecast to 2028
Accessing the in-depth insights from the ‘South Asia Construction’ report can help: Access the historical and forecast valuations of the South Asia construction market in real terms from 2019 to 2028. Examine the sectors and sub-sectors within the South Asia construction market. Foresee shift in the construction landscape for key regional countries including the US and Canada Analyze the mega-project pipeline, including breakdowns by development stage across all sectors. Assess the projected spending on projects in the existing pipeline. Learn...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imatinib Mesylate in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imatinib Mesylate in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imatinib Mesylate in Pulmonary Arterial Hypertension Drug Details: Imatinib mesylate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Renzapride in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Renzapride in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Renzapride in Parkinson's Disease Drug Details: Renzapride (ATL-1251, BRL-24924) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nemtabrutinib in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nemtabrutinib in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nemtabrutinib in Mantle Cell Lymphoma Drug Details: Nemtabrutinib (ARQ-531) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nemtabrutinib in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nemtabrutinib in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nemtabrutinib in B-Cell Non-Hodgkin Lymphoma Drug Details: Nemtabrutinib (ARQ-531) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nemtabrutinib in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nemtabrutinib in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nemtabrutinib in Follicular Lymphoma Drug Details: Nemtabrutinib (ARQ-531) is under development for...